Global PD-L1 Biomarker Testing Market Research Report 2026(Status and Outlook)
PD-L1 Biomarker Testing measures the amount of PDL1 on cancer cells. PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1. This allows the cancer cells to "trick" the immune system, and avoid being attacked as foreign, harmful substances. Current PD-L1 testing is based on immunohistochemistry (IHC) methods. Immunohistochemistry (IHC) is the process whereby antibodies are used to detect proteins (antigens) in cells within a tissue section (for instance liver, pancreas or the heart). PD-L1 is a ligand that binds to PD-1 (programmed cell death-1), expressed on activated T cells, to evade anti-tumor responses. PD-L1 plays a role in inhibiting T cell activation and proliferation and has emerged as an important target in cancer treatment. PD-L1 protein detection by immunohistochemistry (IHC) testing is widely used as a predictive biomarker assay for anti?PD-1/PD-L1 therapies. PDL1 testing is used to find out if you have a cancer that may benefit from immunotherapy.The PD?L1 biomarker testing market is being propelled by the rapid expansion of immune checkpoint inhibitor therapies, particularly those targeting the PD?1/PD?L1 axis, which have shown remarkable clinical success in treating various advanced cancers?spurring widespread demand for stratifying patients based on PD?L1 expression to optimize treatment outcomes. Additionally, the shift toward precision medicine has heightened the importance of molecular diagnostics. Clinicians and pharmaceutical developers are increasingly emphasizing personalized approaches, using PD?L1 testing to guide therapeutic decisions and enable companion diagnostics?especially as diagnostic technologies advance to include automated IHC systems, NGS platforms, and AI-enhanced analysis .Despite these positive trends, the PD?L1 testing landscape faces significant obstacles due to a lack of standardization across protocols, assay clones, scoring systems, and cut-off thresholds. This inconsistency manifests in discordant results (with variability rates reported between 19?32% across different assays), undermining diagnostic reliability and complicating clinical decision-making. Moreover, high costs associated with advanced testing techniques (IHC, NGS) and uneven reimbursement frameworks create economic barriers, particularly in developing regions, impeding broad accessibility and exacerbating healthcare disparities.The classification of PD-L1 Biomarker Testing includes PD-L1 (22C3), PD-L1 (28-8), PD-L1 (SP142), PD-L1 (SP263) and Other, and the revenue proportion of PD-L1 (22C3) in 2024 is about 21.68%. PD-L1 Biomarker Testing is widely used in Hospital and Diagnostic Laboratories. The most proportion of PD-L1 Biomarker Testing is Hospital, and the proportion in 2024 is about 52.7%.
The global PD-L1 Biomarker Testing market size was estimated at USD 2815.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 38.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global PD-L1 Biomarker Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global PD-L1 Biomarker Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the PD-L1 Biomarker Testing market.
Global PD-L1 Biomarker Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Agilent Technologies
Roche
Merck
Bristol-Myers Squibb
AstraZeneca
Ono Pharmaceutical
Regeneron
Innovent
Hengrui Medicine
Junshi Biosciences
Market Segmentation (by Type)
PD-L1 (22C3)
PD-L1(28-8)
PD-L1 (SP142)
PD-L1 (SP263)
Other
Market Segmentation (by Application)
Hospital
Diagnostic Center
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the PD-L1 Biomarker Testing Market
Overview of the regional outlook of the PD-L1 Biomarker Testing Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the PD-L1 Biomarker Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of PD-L1 Biomarker Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global PD-L1 Biomarker Testing market size was estimated at USD 2815.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 38.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global PD-L1 Biomarker Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global PD-L1 Biomarker Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the PD-L1 Biomarker Testing market.
Global PD-L1 Biomarker Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Agilent Technologies
Roche
Merck
Bristol-Myers Squibb
AstraZeneca
Ono Pharmaceutical
Regeneron
Innovent
Hengrui Medicine
Junshi Biosciences
Market Segmentation (by Type)
PD-L1 (22C3)
PD-L1(28-8)
PD-L1 (SP142)
PD-L1 (SP263)
Other
Market Segmentation (by Application)
Hospital
Diagnostic Center
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the PD-L1 Biomarker Testing Market
Overview of the regional outlook of the PD-L1 Biomarker Testing Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the PD-L1 Biomarker Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of PD-L1 Biomarker Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of PD-L1 Biomarker Testing
1.2 Key Market Segments
1.2.1 PD-L1 Biomarker Testing Segment by Type
1.2.2 PD-L1 Biomarker Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PD-L1 BIOMARKER TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global PD-L1 Biomarker Testing Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global PD-L1 Biomarker Testing Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PD-L1 BIOMARKER TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global PD-L1 Biomarker Testing Product Life Cycle
3.3 Global PD-L1 Biomarker Testing Sales by Manufacturers (2020-2025)
3.4 Global PD-L1 Biomarker Testing Revenue Market Share by Manufacturers (2020-2025)
3.5 PD-L1 Biomarker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global PD-L1 Biomarker Testing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 PD-L1 Biomarker Testing Market Competitive Situation and Trends
3.8.1 PD-L1 Biomarker Testing Market Concentration Rate
3.8.2 Global 5 and 10 Largest PD-L1 Biomarker Testing Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PD-L1 BIOMARKER TESTING INDUSTRY CHAIN ANALYSIS
4.1 PD-L1 Biomarker Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PD-L1 BIOMARKER TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global PD-L1 Biomarker Testing Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to PD-L1 Biomarker Testing Market
5.7 ESG Ratings of Leading Companies
6 PD-L1 BIOMARKER TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global PD-L1 Biomarker Testing Sales Market Share by Type (2020-2025)
6.3 Global PD-L1 Biomarker Testing Market Size by Type (2020-2025)
6.4 Global PD-L1 Biomarker Testing Price by Type (2020-2025)
7 PD-L1 BIOMARKER TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global PD-L1 Biomarker Testing Market Sales by Application (2020-2025)
7.3 Global PD-L1 Biomarker Testing Market Size (M USD) by Application (2020-2025)
7.4 Global PD-L1 Biomarker Testing Sales Growth Rate by Application (2020-2025)
8 PD-L1 BIOMARKER TESTING MARKET SALES BY REGION
8.1 Global PD-L1 Biomarker Testing Sales by Region
8.1.1 Global PD-L1 Biomarker Testing Sales by Region
8.1.2 Global PD-L1 Biomarker Testing Sales Market Share by Region
8.2 Global PD-L1 Biomarker Testing Market Size by Region
8.2.1 Global PD-L1 Biomarker Testing Market Size by Region
8.2.2 Global PD-L1 Biomarker Testing Market Size by Region
8.3 North America
8.3.1 North America PD-L1 Biomarker Testing Sales by Country
8.3.2 North America PD-L1 Biomarker Testing Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe PD-L1 Biomarker Testing Sales by Country
8.4.2 Europe PD-L1 Biomarker Testing Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific PD-L1 Biomarker Testing Sales by Region
8.5.2 Asia Pacific PD-L1 Biomarker Testing Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America PD-L1 Biomarker Testing Sales by Country
8.6.2 South America PD-L1 Biomarker Testing Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa PD-L1 Biomarker Testing Sales by Region
8.7.2 Middle East and Africa PD-L1 Biomarker Testing Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PD-L1 BIOMARKER TESTING MARKET PRODUCTION BY REGION
9.1 Global Production of PD-L1 Biomarker Testing by Region(2020-2025)
9.2 Global PD-L1 Biomarker Testing Revenue Market Share by Region (2020-2025)
9.3 Global PD-L1 Biomarker Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America PD-L1 Biomarker Testing Production
9.4.1 North America PD-L1 Biomarker Testing Production Growth Rate (2020-2025)
9.4.2 North America PD-L1 Biomarker Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe PD-L1 Biomarker Testing Production
9.5.1 Europe PD-L1 Biomarker Testing Production Growth Rate (2020-2025)
9.5.2 Europe PD-L1 Biomarker Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan PD-L1 Biomarker Testing Production (2020-2025)
9.6.1 Japan PD-L1 Biomarker Testing Production Growth Rate (2020-2025)
9.6.2 Japan PD-L1 Biomarker Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China PD-L1 Biomarker Testing Production (2020-2025)
9.7.1 China PD-L1 Biomarker Testing Production Growth Rate (2020-2025)
9.7.2 China PD-L1 Biomarker Testing Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Agilent Technologies
10.1.1 Agilent Technologies Basic Information
10.1.2 Agilent Technologies PD-L1 Biomarker Testing Product Overview
10.1.3 Agilent Technologies PD-L1 Biomarker Testing Product Market Performance
10.1.4 Agilent Technologies Business Overview
10.1.5 Agilent Technologies SWOT Analysis
10.1.6 Agilent Technologies Recent Developments
10.2 Roche
10.2.1 Roche Basic Information
10.2.2 Roche PD-L1 Biomarker Testing Product Overview
10.2.3 Roche PD-L1 Biomarker Testing Product Market Performance
10.2.4 Roche Business Overview
10.2.5 Roche SWOT Analysis
10.2.6 Roche Recent Developments
10.3 Merck
10.3.1 Merck Basic Information
10.3.2 Merck PD-L1 Biomarker Testing Product Overview
10.3.3 Merck PD-L1 Biomarker Testing Product Market Performance
10.3.4 Merck Business Overview
10.3.5 Merck SWOT Analysis
10.3.6 Merck Recent Developments
10.4 Bristol-Myers Squibb
10.4.1 Bristol-Myers Squibb Basic Information
10.4.2 Bristol-Myers Squibb PD-L1 Biomarker Testing Product Overview
10.4.3 Bristol-Myers Squibb PD-L1 Biomarker Testing Product Market Performance
10.4.4 Bristol-Myers Squibb Business Overview
10.4.5 Bristol-Myers Squibb Recent Developments
10.5 AstraZeneca
10.5.1 AstraZeneca Basic Information
10.5.2 AstraZeneca PD-L1 Biomarker Testing Product Overview
10.5.3 AstraZeneca PD-L1 Biomarker Testing Product Market Performance
10.5.4 AstraZeneca Business Overview
10.5.5 AstraZeneca Recent Developments
10.6 Ono Pharmaceutical
10.6.1 Ono Pharmaceutical Basic Information
10.6.2 Ono Pharmaceutical PD-L1 Biomarker Testing Product Overview
10.6.3 Ono Pharmaceutical PD-L1 Biomarker Testing Product Market Performance
10.6.4 Ono Pharmaceutical Business Overview
10.6.5 Ono Pharmaceutical Recent Developments
10.7 Regeneron
10.7.1 Regeneron Basic Information
10.7.2 Regeneron PD-L1 Biomarker Testing Product Overview
10.7.3 Regeneron PD-L1 Biomarker Testing Product Market Performance
10.7.4 Regeneron Business Overview
10.7.5 Regeneron Recent Developments
10.8 Innovent
10.8.1 Innovent Basic Information
10.8.2 Innovent PD-L1 Biomarker Testing Product Overview
10.8.3 Innovent PD-L1 Biomarker Testing Product Market Performance
10.8.4 Innovent Business Overview
10.8.5 Innovent Recent Developments
10.9 Hengrui Medicine
10.9.1 Hengrui Medicine Basic Information
10.9.2 Hengrui Medicine PD-L1 Biomarker Testing Product Overview
10.9.3 Hengrui Medicine PD-L1 Biomarker Testing Product Market Performance
10.9.4 Hengrui Medicine Business Overview
10.9.5 Hengrui Medicine Recent Developments
10.10 Junshi Biosciences
10.10.1 Junshi Biosciences Basic Information
10.10.2 Junshi Biosciences PD-L1 Biomarker Testing Product Overview
10.10.3 Junshi Biosciences PD-L1 Biomarker Testing Product Market Performance
10.10.4 Junshi Biosciences Business Overview
10.10.5 Junshi Biosciences Recent Developments
11 PD-L1 BIOMARKER TESTING MARKET FORECAST BY REGION
11.1 Global PD-L1 Biomarker Testing Market Size Forecast
11.2 Global PD-L1 Biomarker Testing Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe PD-L1 Biomarker Testing Market Size Forecast by Country
11.2.3 Asia Pacific PD-L1 Biomarker Testing Market Size Forecast by Region
11.2.4 South America PD-L1 Biomarker Testing Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of PD-L1 Biomarker Testing by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global PD-L1 Biomarker Testing Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of PD-L1 Biomarker Testing by Type (2026-2035)
12.1.2 Global PD-L1 Biomarker Testing Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of PD-L1 Biomarker Testing by Type (2026-2035)
12.2 Global PD-L1 Biomarker Testing Market Forecast by Application (2026-2035)
12.2.1 Global PD-L1 Biomarker Testing Sales (K Units) Forecast by Application
12.2.2 Global PD-L1 Biomarker Testing Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of PD-L1 Biomarker Testing
1.2 Key Market Segments
1.2.1 PD-L1 Biomarker Testing Segment by Type
1.2.2 PD-L1 Biomarker Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PD-L1 BIOMARKER TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global PD-L1 Biomarker Testing Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global PD-L1 Biomarker Testing Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PD-L1 BIOMARKER TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global PD-L1 Biomarker Testing Product Life Cycle
3.3 Global PD-L1 Biomarker Testing Sales by Manufacturers (2020-2025)
3.4 Global PD-L1 Biomarker Testing Revenue Market Share by Manufacturers (2020-2025)
3.5 PD-L1 Biomarker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global PD-L1 Biomarker Testing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 PD-L1 Biomarker Testing Market Competitive Situation and Trends
3.8.1 PD-L1 Biomarker Testing Market Concentration Rate
3.8.2 Global 5 and 10 Largest PD-L1 Biomarker Testing Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PD-L1 BIOMARKER TESTING INDUSTRY CHAIN ANALYSIS
4.1 PD-L1 Biomarker Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PD-L1 BIOMARKER TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global PD-L1 Biomarker Testing Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to PD-L1 Biomarker Testing Market
5.7 ESG Ratings of Leading Companies
6 PD-L1 BIOMARKER TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global PD-L1 Biomarker Testing Sales Market Share by Type (2020-2025)
6.3 Global PD-L1 Biomarker Testing Market Size by Type (2020-2025)
6.4 Global PD-L1 Biomarker Testing Price by Type (2020-2025)
7 PD-L1 BIOMARKER TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global PD-L1 Biomarker Testing Market Sales by Application (2020-2025)
7.3 Global PD-L1 Biomarker Testing Market Size (M USD) by Application (2020-2025)
7.4 Global PD-L1 Biomarker Testing Sales Growth Rate by Application (2020-2025)
8 PD-L1 BIOMARKER TESTING MARKET SALES BY REGION
8.1 Global PD-L1 Biomarker Testing Sales by Region
8.1.1 Global PD-L1 Biomarker Testing Sales by Region
8.1.2 Global PD-L1 Biomarker Testing Sales Market Share by Region
8.2 Global PD-L1 Biomarker Testing Market Size by Region
8.2.1 Global PD-L1 Biomarker Testing Market Size by Region
8.2.2 Global PD-L1 Biomarker Testing Market Size by Region
8.3 North America
8.3.1 North America PD-L1 Biomarker Testing Sales by Country
8.3.2 North America PD-L1 Biomarker Testing Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe PD-L1 Biomarker Testing Sales by Country
8.4.2 Europe PD-L1 Biomarker Testing Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific PD-L1 Biomarker Testing Sales by Region
8.5.2 Asia Pacific PD-L1 Biomarker Testing Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America PD-L1 Biomarker Testing Sales by Country
8.6.2 South America PD-L1 Biomarker Testing Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa PD-L1 Biomarker Testing Sales by Region
8.7.2 Middle East and Africa PD-L1 Biomarker Testing Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PD-L1 BIOMARKER TESTING MARKET PRODUCTION BY REGION
9.1 Global Production of PD-L1 Biomarker Testing by Region(2020-2025)
9.2 Global PD-L1 Biomarker Testing Revenue Market Share by Region (2020-2025)
9.3 Global PD-L1 Biomarker Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America PD-L1 Biomarker Testing Production
9.4.1 North America PD-L1 Biomarker Testing Production Growth Rate (2020-2025)
9.4.2 North America PD-L1 Biomarker Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe PD-L1 Biomarker Testing Production
9.5.1 Europe PD-L1 Biomarker Testing Production Growth Rate (2020-2025)
9.5.2 Europe PD-L1 Biomarker Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan PD-L1 Biomarker Testing Production (2020-2025)
9.6.1 Japan PD-L1 Biomarker Testing Production Growth Rate (2020-2025)
9.6.2 Japan PD-L1 Biomarker Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China PD-L1 Biomarker Testing Production (2020-2025)
9.7.1 China PD-L1 Biomarker Testing Production Growth Rate (2020-2025)
9.7.2 China PD-L1 Biomarker Testing Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Agilent Technologies
10.1.1 Agilent Technologies Basic Information
10.1.2 Agilent Technologies PD-L1 Biomarker Testing Product Overview
10.1.3 Agilent Technologies PD-L1 Biomarker Testing Product Market Performance
10.1.4 Agilent Technologies Business Overview
10.1.5 Agilent Technologies SWOT Analysis
10.1.6 Agilent Technologies Recent Developments
10.2 Roche
10.2.1 Roche Basic Information
10.2.2 Roche PD-L1 Biomarker Testing Product Overview
10.2.3 Roche PD-L1 Biomarker Testing Product Market Performance
10.2.4 Roche Business Overview
10.2.5 Roche SWOT Analysis
10.2.6 Roche Recent Developments
10.3 Merck
10.3.1 Merck Basic Information
10.3.2 Merck PD-L1 Biomarker Testing Product Overview
10.3.3 Merck PD-L1 Biomarker Testing Product Market Performance
10.3.4 Merck Business Overview
10.3.5 Merck SWOT Analysis
10.3.6 Merck Recent Developments
10.4 Bristol-Myers Squibb
10.4.1 Bristol-Myers Squibb Basic Information
10.4.2 Bristol-Myers Squibb PD-L1 Biomarker Testing Product Overview
10.4.3 Bristol-Myers Squibb PD-L1 Biomarker Testing Product Market Performance
10.4.4 Bristol-Myers Squibb Business Overview
10.4.5 Bristol-Myers Squibb Recent Developments
10.5 AstraZeneca
10.5.1 AstraZeneca Basic Information
10.5.2 AstraZeneca PD-L1 Biomarker Testing Product Overview
10.5.3 AstraZeneca PD-L1 Biomarker Testing Product Market Performance
10.5.4 AstraZeneca Business Overview
10.5.5 AstraZeneca Recent Developments
10.6 Ono Pharmaceutical
10.6.1 Ono Pharmaceutical Basic Information
10.6.2 Ono Pharmaceutical PD-L1 Biomarker Testing Product Overview
10.6.3 Ono Pharmaceutical PD-L1 Biomarker Testing Product Market Performance
10.6.4 Ono Pharmaceutical Business Overview
10.6.5 Ono Pharmaceutical Recent Developments
10.7 Regeneron
10.7.1 Regeneron Basic Information
10.7.2 Regeneron PD-L1 Biomarker Testing Product Overview
10.7.3 Regeneron PD-L1 Biomarker Testing Product Market Performance
10.7.4 Regeneron Business Overview
10.7.5 Regeneron Recent Developments
10.8 Innovent
10.8.1 Innovent Basic Information
10.8.2 Innovent PD-L1 Biomarker Testing Product Overview
10.8.3 Innovent PD-L1 Biomarker Testing Product Market Performance
10.8.4 Innovent Business Overview
10.8.5 Innovent Recent Developments
10.9 Hengrui Medicine
10.9.1 Hengrui Medicine Basic Information
10.9.2 Hengrui Medicine PD-L1 Biomarker Testing Product Overview
10.9.3 Hengrui Medicine PD-L1 Biomarker Testing Product Market Performance
10.9.4 Hengrui Medicine Business Overview
10.9.5 Hengrui Medicine Recent Developments
10.10 Junshi Biosciences
10.10.1 Junshi Biosciences Basic Information
10.10.2 Junshi Biosciences PD-L1 Biomarker Testing Product Overview
10.10.3 Junshi Biosciences PD-L1 Biomarker Testing Product Market Performance
10.10.4 Junshi Biosciences Business Overview
10.10.5 Junshi Biosciences Recent Developments
11 PD-L1 BIOMARKER TESTING MARKET FORECAST BY REGION
11.1 Global PD-L1 Biomarker Testing Market Size Forecast
11.2 Global PD-L1 Biomarker Testing Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe PD-L1 Biomarker Testing Market Size Forecast by Country
11.2.3 Asia Pacific PD-L1 Biomarker Testing Market Size Forecast by Region
11.2.4 South America PD-L1 Biomarker Testing Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of PD-L1 Biomarker Testing by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global PD-L1 Biomarker Testing Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of PD-L1 Biomarker Testing by Type (2026-2035)
12.1.2 Global PD-L1 Biomarker Testing Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of PD-L1 Biomarker Testing by Type (2026-2035)
12.2 Global PD-L1 Biomarker Testing Market Forecast by Application (2026-2035)
12.2.1 Global PD-L1 Biomarker Testing Sales (K Units) Forecast by Application
12.2.2 Global PD-L1 Biomarker Testing Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global PD-L1 Biomarker Testing Market Size by Type (M USD)
Table 4. Global PD-L1 Biomarker Testing Market Size by Application
Table 5. PD-L1 Biomarker Testing Market Size Comparison by Region (M USD)
Table 6. Global PD-L1 Biomarker Testing Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global PD-L1 Biomarker Testing Sales Market Share by Manufacturers (2020-2025)
Table 8. Global PD-L1 Biomarker Testing Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global PD-L1 Biomarker Testing Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 Biomarker Testing as of 2025)
Table 11. Global Market PD-L1 Biomarker Testing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global PD-L1 Biomarker Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. PD-L1 Biomarker Testing Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global PD-L1 Biomarker Testing Sales by Type (K Units)
Table 27. Global PD-L1 Biomarker Testing Market Size by Type (M USD)
Table 28. Global PD-L1 Biomarker Testing Sales (K Units) by Type (2020-2025)
Table 29. Global PD-L1 Biomarker Testing Sales Market Share by Type (2020-2025)
Table 30. Global PD-L1 Biomarker Testing Market Size (M USD) by Type (2020-2025)
Table 31. Global PD-L1 Biomarker Testing Market Share by Type (2020-2025)
Table 32. Global PD-L1 Biomarker Testing Price (USD/Unit) by Type (2020-2025)
Table 33. Global PD-L1 Biomarker Testing Sales (K Units) by Application
Table 34. Global PD-L1 Biomarker Testing Market Size by Application
Table 35. Global PD-L1 Biomarker Testing Sales by Application (2020-2025) & (K Units)
Table 36. Global PD-L1 Biomarker Testing Sales Market Share by Application (2020-2025)
Table 37. Global PD-L1 Biomarker Testing Market Size by Application (2020-2025) & (M USD)
Table 38. Global PD-L1 Biomarker Testing Market Share by Application (2020-2025)
Table 39. Global PD-L1 Biomarker Testing Sales Growth Rate by Application (2020-2025)
Table 40. Global PD-L1 Biomarker Testing Sales by Region (2020-2025) & (K Units)
Table 41. Global PD-L1 Biomarker Testing Sales Market Share by Region (2020-2025)
Table 42. Global PD-L1 Biomarker Testing Market Size by Region (2020-2025) & (M USD)
Table 43. Global PD-L1 Biomarker Testing Market Size by Region (2020-2025)
Table 44. North America PD-L1 Biomarker Testing Sales by Country (2020-2025) & (K Units)
Table 45. North America PD-L1 Biomarker Testing Market Size by Country (2020-2025) & (M USD)
Table 46. Europe PD-L1 Biomarker Testing Sales by Country (2020-2025) & (K Units)
Table 47. Europe PD-L1 Biomarker Testing Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific PD-L1 Biomarker Testing Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific PD-L1 Biomarker Testing Market Size by Region (2020-2025) & (M USD)
Table 50. South America PD-L1 Biomarker Testing Sales by Country (2020-2025) & (K Units)
Table 51. South America PD-L1 Biomarker Testing Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa PD-L1 Biomarker Testing Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa PD-L1 Biomarker Testing Market Size by Region (2020-2025) & (M USD)
Table 54. Global PD-L1 Biomarker Testing Production (K Units) by Region(2020-2025)
Table 55. Global PD-L1 Biomarker Testing Revenue (US$ Million) by Region (2020-2025)
Table 56. Global PD-L1 Biomarker Testing Revenue Market Share by Region (2020-2025)
Table 57. Global PD-L1 Biomarker Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America PD-L1 Biomarker Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe PD-L1 Biomarker Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan PD-L1 Biomarker Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China PD-L1 Biomarker Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Agilent Technologies Basic Information
Table 63. Agilent Technologies PD-L1 Biomarker Testing Product Overview
Table 64. Agilent Technologies PD-L1 Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Agilent Technologies Business Overview
Table 66. Agilent Technologies SWOT Analysis
Table 67. Agilent Technologies Recent Developments
Table 68. Roche Basic Information
Table 69. Roche PD-L1 Biomarker Testing Product Overview
Table 70. Roche PD-L1 Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Roche Business Overview
Table 72. Roche SWOT Analysis
Table 73. Roche Recent Developments
Table 74. Merck Basic Information
Table 75. Merck PD-L1 Biomarker Testing Product Overview
Table 76. Merck PD-L1 Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Merck Business Overview
Table 78. Merck SWOT Analysis
Table 79. Merck Recent Developments
Table 80. Bristol-Myers Squibb Basic Information
Table 81. Bristol-Myers Squibb PD-L1 Biomarker Testing Product Overview
Table 82. Bristol-Myers Squibb PD-L1 Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Bristol-Myers Squibb Business Overview
Table 84. Bristol-Myers Squibb Recent Developments
Table 85. AstraZeneca Basic Information
Table 86. AstraZeneca PD-L1 Biomarker Testing Product Overview
Table 87. AstraZeneca PD-L1 Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca Recent Developments
Table 90. Ono Pharmaceutical Basic Information
Table 91. Ono Pharmaceutical PD-L1 Biomarker Testing Product Overview
Table 92. Ono Pharmaceutical PD-L1 Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Ono Pharmaceutical Business Overview
Table 94. Ono Pharmaceutical Recent Developments
Table 95. Regeneron Basic Information
Table 96. Regeneron PD-L1 Biomarker Testing Product Overview
Table 97. Regeneron PD-L1 Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Regeneron Business Overview
Table 99. Regeneron Recent Developments
Table 100. Innovent Basic Information
Table 101. Innovent PD-L1 Biomarker Testing Product Overview
Table 102. Innovent PD-L1 Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Innovent Business Overview
Table 104. Innovent Recent Developments
Table 105. Hengrui Medicine Basic Information
Table 106. Hengrui Medicine PD-L1 Biomarker Testing Product Overview
Table 107. Hengrui Medicine PD-L1 Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Hengrui Medicine Business Overview
Table 109. Hengrui Medicine Recent Developments
Table 110. Junshi Biosciences Basic Information
Table 111. Junshi Biosciences PD-L1 Biomarker Testing Product Overview
Table 112. Junshi Biosciences PD-L1 Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Junshi Biosciences Business Overview
Table 114. Junshi Biosciences Recent Developments
Table 115. Global PD-L1 Biomarker Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 116. Global PD-L1 Biomarker Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America PD-L1 Biomarker Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 118. North America PD-L1 Biomarker Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe PD-L1 Biomarker Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 120. Europe PD-L1 Biomarker Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific PD-L1 Biomarker Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 122. Asia Pacific PD-L1 Biomarker Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America PD-L1 Biomarker Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 124. South America PD-L1 Biomarker Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa PD-L1 Biomarker Testing Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa PD-L1 Biomarker Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global PD-L1 Biomarker Testing Sales Forecast by Type (2026-2035) & (K Units)
Table 128. Global PD-L1 Biomarker Testing Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global PD-L1 Biomarker Testing Price Forecast by Type (2026-2035) & (USD/Unit)
Table 130. Global PD-L1 Biomarker Testing Sales (K Units) Forecast by Application (2026-2035)
Table 131. Global PD-L1 Biomarker Testing Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global PD-L1 Biomarker Testing Market Size by Type (M USD)
Table 4. Global PD-L1 Biomarker Testing Market Size by Application
Table 5. PD-L1 Biomarker Testing Market Size Comparison by Region (M USD)
Table 6. Global PD-L1 Biomarker Testing Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global PD-L1 Biomarker Testing Sales Market Share by Manufacturers (2020-2025)
Table 8. Global PD-L1 Biomarker Testing Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global PD-L1 Biomarker Testing Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 Biomarker Testing as of 2025)
Table 11. Global Market PD-L1 Biomarker Testing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global PD-L1 Biomarker Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. PD-L1 Biomarker Testing Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global PD-L1 Biomarker Testing Sales by Type (K Units)
Table 27. Global PD-L1 Biomarker Testing Market Size by Type (M USD)
Table 28. Global PD-L1 Biomarker Testing Sales (K Units) by Type (2020-2025)
Table 29. Global PD-L1 Biomarker Testing Sales Market Share by Type (2020-2025)
Table 30. Global PD-L1 Biomarker Testing Market Size (M USD) by Type (2020-2025)
Table 31. Global PD-L1 Biomarker Testing Market Share by Type (2020-2025)
Table 32. Global PD-L1 Biomarker Testing Price (USD/Unit) by Type (2020-2025)
Table 33. Global PD-L1 Biomarker Testing Sales (K Units) by Application
Table 34. Global PD-L1 Biomarker Testing Market Size by Application
Table 35. Global PD-L1 Biomarker Testing Sales by Application (2020-2025) & (K Units)
Table 36. Global PD-L1 Biomarker Testing Sales Market Share by Application (2020-2025)
Table 37. Global PD-L1 Biomarker Testing Market Size by Application (2020-2025) & (M USD)
Table 38. Global PD-L1 Biomarker Testing Market Share by Application (2020-2025)
Table 39. Global PD-L1 Biomarker Testing Sales Growth Rate by Application (2020-2025)
Table 40. Global PD-L1 Biomarker Testing Sales by Region (2020-2025) & (K Units)
Table 41. Global PD-L1 Biomarker Testing Sales Market Share by Region (2020-2025)
Table 42. Global PD-L1 Biomarker Testing Market Size by Region (2020-2025) & (M USD)
Table 43. Global PD-L1 Biomarker Testing Market Size by Region (2020-2025)
Table 44. North America PD-L1 Biomarker Testing Sales by Country (2020-2025) & (K Units)
Table 45. North America PD-L1 Biomarker Testing Market Size by Country (2020-2025) & (M USD)
Table 46. Europe PD-L1 Biomarker Testing Sales by Country (2020-2025) & (K Units)
Table 47. Europe PD-L1 Biomarker Testing Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific PD-L1 Biomarker Testing Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific PD-L1 Biomarker Testing Market Size by Region (2020-2025) & (M USD)
Table 50. South America PD-L1 Biomarker Testing Sales by Country (2020-2025) & (K Units)
Table 51. South America PD-L1 Biomarker Testing Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa PD-L1 Biomarker Testing Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa PD-L1 Biomarker Testing Market Size by Region (2020-2025) & (M USD)
Table 54. Global PD-L1 Biomarker Testing Production (K Units) by Region(2020-2025)
Table 55. Global PD-L1 Biomarker Testing Revenue (US$ Million) by Region (2020-2025)
Table 56. Global PD-L1 Biomarker Testing Revenue Market Share by Region (2020-2025)
Table 57. Global PD-L1 Biomarker Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America PD-L1 Biomarker Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe PD-L1 Biomarker Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan PD-L1 Biomarker Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China PD-L1 Biomarker Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Agilent Technologies Basic Information
Table 63. Agilent Technologies PD-L1 Biomarker Testing Product Overview
Table 64. Agilent Technologies PD-L1 Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Agilent Technologies Business Overview
Table 66. Agilent Technologies SWOT Analysis
Table 67. Agilent Technologies Recent Developments
Table 68. Roche Basic Information
Table 69. Roche PD-L1 Biomarker Testing Product Overview
Table 70. Roche PD-L1 Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Roche Business Overview
Table 72. Roche SWOT Analysis
Table 73. Roche Recent Developments
Table 74. Merck Basic Information
Table 75. Merck PD-L1 Biomarker Testing Product Overview
Table 76. Merck PD-L1 Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Merck Business Overview
Table 78. Merck SWOT Analysis
Table 79. Merck Recent Developments
Table 80. Bristol-Myers Squibb Basic Information
Table 81. Bristol-Myers Squibb PD-L1 Biomarker Testing Product Overview
Table 82. Bristol-Myers Squibb PD-L1 Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Bristol-Myers Squibb Business Overview
Table 84. Bristol-Myers Squibb Recent Developments
Table 85. AstraZeneca Basic Information
Table 86. AstraZeneca PD-L1 Biomarker Testing Product Overview
Table 87. AstraZeneca PD-L1 Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca Recent Developments
Table 90. Ono Pharmaceutical Basic Information
Table 91. Ono Pharmaceutical PD-L1 Biomarker Testing Product Overview
Table 92. Ono Pharmaceutical PD-L1 Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Ono Pharmaceutical Business Overview
Table 94. Ono Pharmaceutical Recent Developments
Table 95. Regeneron Basic Information
Table 96. Regeneron PD-L1 Biomarker Testing Product Overview
Table 97. Regeneron PD-L1 Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Regeneron Business Overview
Table 99. Regeneron Recent Developments
Table 100. Innovent Basic Information
Table 101. Innovent PD-L1 Biomarker Testing Product Overview
Table 102. Innovent PD-L1 Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Innovent Business Overview
Table 104. Innovent Recent Developments
Table 105. Hengrui Medicine Basic Information
Table 106. Hengrui Medicine PD-L1 Biomarker Testing Product Overview
Table 107. Hengrui Medicine PD-L1 Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Hengrui Medicine Business Overview
Table 109. Hengrui Medicine Recent Developments
Table 110. Junshi Biosciences Basic Information
Table 111. Junshi Biosciences PD-L1 Biomarker Testing Product Overview
Table 112. Junshi Biosciences PD-L1 Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Junshi Biosciences Business Overview
Table 114. Junshi Biosciences Recent Developments
Table 115. Global PD-L1 Biomarker Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 116. Global PD-L1 Biomarker Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America PD-L1 Biomarker Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 118. North America PD-L1 Biomarker Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe PD-L1 Biomarker Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 120. Europe PD-L1 Biomarker Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific PD-L1 Biomarker Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 122. Asia Pacific PD-L1 Biomarker Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America PD-L1 Biomarker Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 124. South America PD-L1 Biomarker Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa PD-L1 Biomarker Testing Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa PD-L1 Biomarker Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global PD-L1 Biomarker Testing Sales Forecast by Type (2026-2035) & (K Units)
Table 128. Global PD-L1 Biomarker Testing Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global PD-L1 Biomarker Testing Price Forecast by Type (2026-2035) & (USD/Unit)
Table 130. Global PD-L1 Biomarker Testing Sales (K Units) Forecast by Application (2026-2035)
Table 131. Global PD-L1 Biomarker Testing Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of PD-L1 Biomarker Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global PD-L1 Biomarker Testing Market Size (M USD), 2025-2035
Figure 5. Global PD-L1 Biomarker Testing Market Size (M USD) (2020-2035)
Figure 6. Global PD-L1 Biomarker Testing Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. PD-L1 Biomarker Testing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global PD-L1 Biomarker Testing Product Life Cycle
Figure 13. PD-L1 Biomarker Testing Sales Share by Manufacturers in 2025
Figure 14. Global PD-L1 Biomarker Testing Revenue Share by Manufacturers in 2025
Figure 15. PD-L1 Biomarker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market PD-L1 Biomarker Testing Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by PD-L1 Biomarker Testing Revenue in 2025
Figure 18. Industry Chain Map of PD-L1 Biomarker Testing
Figure 19. Global PD-L1 Biomarker Testing Market PEST Analysis
Figure 20. Global PD-L1 Biomarker Testing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global PD-L1 Biomarker Testing Market Share by Type
Figure 27. Sales Market Share of PD-L1 Biomarker Testing by Type (2020-2025)
Figure 28. Sales Market Share of PD-L1 Biomarker Testing by Type in 2025
Figure 29. Market Share of PD-L1 Biomarker Testing by Type (2020-2025)
Figure 30. Market Share of PD-L1 Biomarker Testing by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global PD-L1 Biomarker Testing Market Share by Application
Figure 33. Global PD-L1 Biomarker Testing Sales Market Share by Application (2020-2025)
Figure 34. Global PD-L1 Biomarker Testing Sales Market Share by Application in 2025
Figure 35. Global PD-L1 Biomarker Testing Market Share by Application (2020-2025)
Figure 36. Global PD-L1 Biomarker Testing Market Share by Application in 2025
Figure 37. Global PD-L1 Biomarker Testing Sales Growth Rate by Application (2020-2025)
Figure 38. Global PD-L1 Biomarker Testing Sales Market Share by Region (2020-2025)
Figure 39. Global PD-L1 Biomarker Testing Market Size by Region (2020-2025)
Figure 40. North America PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America PD-L1 Biomarker Testing Sales Market Share by Country in 2024
Figure 43. North America PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America PD-L1 Biomarker Testing Market Size by Country in 2024
Figure 45. U.S. PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada PD-L1 Biomarker Testing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada PD-L1 Biomarker Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico PD-L1 Biomarker Testing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico PD-L1 Biomarker Testing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe PD-L1 Biomarker Testing Sales Market Share by Country in 2024
Figure 53. Europe PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe PD-L1 Biomarker Testing Market Size by Country in 2024
Figure 55. Germany PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific PD-L1 Biomarker Testing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific PD-L1 Biomarker Testing Sales Market Share by Region in 2024
Figure 67. Asia Pacific PD-L1 Biomarker Testing Market Size by Region in 2024
Figure 68. China PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America PD-L1 Biomarker Testing Sales and Growth Rate (K Units)
Figure 79. South America PD-L1 Biomarker Testing Sales Market Share by Country in 2024
Figure 80. South America PD-L1 Biomarker Testing Market Size and Growth Rate (M USD)
Figure 81. South America PD-L1 Biomarker Testing Market Size by Country in 2024
Figure 82. Brazil PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa PD-L1 Biomarker Testing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa PD-L1 Biomarker Testing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa PD-L1 Biomarker Testing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa PD-L1 Biomarker Testing Market Size by Region in 2024
Figure 92. Saudi Arabia PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global PD-L1 Biomarker Testing Production Market Share by Region (2020-2025)
Figure 103. North America PD-L1 Biomarker Testing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe PD-L1 Biomarker Testing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan PD-L1 Biomarker Testing Production (K Units) Growth Rate (2020-2025)
Figure 106. China PD-L1 Biomarker Testing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global PD-L1 Biomarker Testing Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global PD-L1 Biomarker Testing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global PD-L1 Biomarker Testing Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global PD-L1 Biomarker Testing Market Share Forecast by Type (2026-2035)
Figure 111. Global PD-L1 Biomarker Testing Sales Forecast by Application (2026-2035)
Figure 112. Global PD-L1 Biomarker Testing Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of PD-L1 Biomarker Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global PD-L1 Biomarker Testing Market Size (M USD), 2025-2035
Figure 5. Global PD-L1 Biomarker Testing Market Size (M USD) (2020-2035)
Figure 6. Global PD-L1 Biomarker Testing Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. PD-L1 Biomarker Testing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global PD-L1 Biomarker Testing Product Life Cycle
Figure 13. PD-L1 Biomarker Testing Sales Share by Manufacturers in 2025
Figure 14. Global PD-L1 Biomarker Testing Revenue Share by Manufacturers in 2025
Figure 15. PD-L1 Biomarker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market PD-L1 Biomarker Testing Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by PD-L1 Biomarker Testing Revenue in 2025
Figure 18. Industry Chain Map of PD-L1 Biomarker Testing
Figure 19. Global PD-L1 Biomarker Testing Market PEST Analysis
Figure 20. Global PD-L1 Biomarker Testing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global PD-L1 Biomarker Testing Market Share by Type
Figure 27. Sales Market Share of PD-L1 Biomarker Testing by Type (2020-2025)
Figure 28. Sales Market Share of PD-L1 Biomarker Testing by Type in 2025
Figure 29. Market Share of PD-L1 Biomarker Testing by Type (2020-2025)
Figure 30. Market Share of PD-L1 Biomarker Testing by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global PD-L1 Biomarker Testing Market Share by Application
Figure 33. Global PD-L1 Biomarker Testing Sales Market Share by Application (2020-2025)
Figure 34. Global PD-L1 Biomarker Testing Sales Market Share by Application in 2025
Figure 35. Global PD-L1 Biomarker Testing Market Share by Application (2020-2025)
Figure 36. Global PD-L1 Biomarker Testing Market Share by Application in 2025
Figure 37. Global PD-L1 Biomarker Testing Sales Growth Rate by Application (2020-2025)
Figure 38. Global PD-L1 Biomarker Testing Sales Market Share by Region (2020-2025)
Figure 39. Global PD-L1 Biomarker Testing Market Size by Region (2020-2025)
Figure 40. North America PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America PD-L1 Biomarker Testing Sales Market Share by Country in 2024
Figure 43. North America PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America PD-L1 Biomarker Testing Market Size by Country in 2024
Figure 45. U.S. PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada PD-L1 Biomarker Testing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada PD-L1 Biomarker Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico PD-L1 Biomarker Testing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico PD-L1 Biomarker Testing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe PD-L1 Biomarker Testing Sales Market Share by Country in 2024
Figure 53. Europe PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe PD-L1 Biomarker Testing Market Size by Country in 2024
Figure 55. Germany PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific PD-L1 Biomarker Testing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific PD-L1 Biomarker Testing Sales Market Share by Region in 2024
Figure 67. Asia Pacific PD-L1 Biomarker Testing Market Size by Region in 2024
Figure 68. China PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America PD-L1 Biomarker Testing Sales and Growth Rate (K Units)
Figure 79. South America PD-L1 Biomarker Testing Sales Market Share by Country in 2024
Figure 80. South America PD-L1 Biomarker Testing Market Size and Growth Rate (M USD)
Figure 81. South America PD-L1 Biomarker Testing Market Size by Country in 2024
Figure 82. Brazil PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa PD-L1 Biomarker Testing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa PD-L1 Biomarker Testing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa PD-L1 Biomarker Testing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa PD-L1 Biomarker Testing Market Size by Region in 2024
Figure 92. Saudi Arabia PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa PD-L1 Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa PD-L1 Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global PD-L1 Biomarker Testing Production Market Share by Region (2020-2025)
Figure 103. North America PD-L1 Biomarker Testing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe PD-L1 Biomarker Testing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan PD-L1 Biomarker Testing Production (K Units) Growth Rate (2020-2025)
Figure 106. China PD-L1 Biomarker Testing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global PD-L1 Biomarker Testing Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global PD-L1 Biomarker Testing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global PD-L1 Biomarker Testing Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global PD-L1 Biomarker Testing Market Share Forecast by Type (2026-2035)
Figure 111. Global PD-L1 Biomarker Testing Sales Forecast by Application (2026-2035)
Figure 112. Global PD-L1 Biomarker Testing Market Share Forecast by Application (2026-2035)
